Diethylene glycol monomethyl ether, often abbreviated DEGME or DiEGME, is a colorless, water-soluble liquid belonging to the glycol ether family of industrial solvents. It shows up in jet fuel as an anti-icing additive, in brake fluids, in certain paints and coatings, and in specialty chemical formulations. While it is less acutely dangerous than some of its close chemical relatives, DEGME has drawn sustained attention from toxicologists because it can cause developmental harm in animal studies, passes readily through the skin, and breaks down in the body into a metabolite linked to reproductive and blood-cell damage.
Where You Encounter It
The single largest use of DEGME that most people will never think about is inside jet fuel. Military jet fuel JP-8, along with older formulations such as JP-4 and JP-5, commonly contains small concentrations of DEGME as a fuel system icing inhibitor. A NIOSH industrial hygiene survey at a Defense Fuel Support Point found JP-5 arriving with DEGME at roughly 0.15 to 0.20 percent by weight.1National Institute for Occupational Safety and Health. Industrial hygiene survey report of Defense Fuel Support Point, Cincinnati, Ohio That sounds like a trace amount, and it is, but fuel handlers on military bases and commercial airfields can come into contact with thousands of gallons per shift. Because DEGME absorbs efficiently through the skin, even splash exposures during refueling, maintenance, or fuel transfer become a health concern rather than a mere nuisance.
Outside of aviation, DEGME appears as a solvent or coalescing agent in some paints, lacquers, and cleaning products. It is also used in chemical synthesis. Researchers have explored it as a building block for specialty biolubricants derived from palm fatty acids, with possible applications in hydraulic oil and metal-cutting fluids.2PubMed Central. Preparation and Physicochemical Properties of a New Biolubricant from Epoxidized Fatty Acids and Diethylene Glycol Monomethyl Ether In all these settings, the practical question is the same: how much can get into your body, and what does it do once it’s there?
How the Body Breaks It Down
Once absorbed, DEGME follows a metabolic path that toxicologists find familiar because it mirrors what happens with its shorter-chain cousin, ethylene glycol monomethyl ether (EGME). The body’s alcohol dehydrogenase enzymes oxidize the terminal hydroxyl group on the molecule, ultimately producing an acid metabolite. For DEGME, that acid is (2-methoxyethoxy)acetic acid, abbreviated MEAA. A rat study confirmed that this oxidation pathway dominates, just as it does for EGME.3PubMed. The urinary metabolic profile of diethylene glycol methyl ether and triethylene glycol methyl ether in Sprague-Dawley rats and the role of the metabolite methoxyacetic acid in their toxicity
MEAA is the metabolite that causes most of the trouble. It belongs to a class of alkoxyacetic acids that are broadly responsible for the toxicity seen across the glycol ether family. The parent compound itself is relatively unremarkable; it is the enzymatic conversion to the acid form that unlocks the capacity to damage developing tissues and blood cells. This matters for anyone thinking about treatment after an accidental exposure: blocking the enzyme that creates the acid metabolite is one therapeutic strategy, which is why fomepizole (an alcohol dehydrogenase inhibitor) has been tried in glycol ether poisoning cases.
Reproductive and Developmental Toxicity
The bulk of the safety concern around DEGME centers on what it does to developing embryos and fetuses in animal studies. This is the toxicological profile that has driven workplace exposure limits and triggered regulatory warnings.
In one teratology study, pregnant Sprague-Dawley rats given DEGME orally on days 7 through 16 of gestation showed a steep, dose-dependent rise in birth defects. Even at the lowest dose tested (720 mg/kg/day), rib malformations appeared in about 43 percent of litters, compared to roughly 9 percent in controls. At 2,165 mg/kg/day, rib malformations hit 80 percent of litters, and cardiovascular malformations appeared in over 71 percent. At the highest dose of 5,175 mg/kg/day, all surviving litters were completely resorbed.4Fundamental and Applied Toxicology. Developmental toxicity of diethylene glycol monomethyl ether (diEGME)
A separate study in Wistar rats confirmed the pattern but noted that the specific types of malformations differed somewhat between rat strains. At 1,800 mg/kg/day, cardiovascular malformations appeared in 28 percent of fetuses, and only about 6 percent of pups born to dams at that dose survived past four days. The thymus turned out to be an especially sensitive target organ in both mothers and fetuses. At a moderate dose of 600 mg/kg/day, dams appeared healthy, but fetal body weights dropped and fetal thymus development was impaired. A dose of 200 mg/kg/day produced no detectable adverse effects in dams, fetuses, or neonates.5PubMed. Effects of diethylene glycol monomethyl ether on pregnancy and postnatal development in rats
Rabbits have also been studied, though by the dermal route rather than oral dosing. Pregnant rabbits receiving DEGME on the skin at 750 mg/kg/day showed mild embryotoxicity and fetotoxicity, including delayed bone formation and slight increases in embryonic resorptions. At 250 mg/kg/day, mild delayed ossification of the skull was still detectable. Only the lowest dose of 50 mg/kg/day produced no adverse effects at all.6Fundamental and Applied Toxicology. Teratologic evaluation of dermally applied diethylene glycol monomethyl ether in rabbits The rabbit study is especially relevant because dermal exposure is the primary route for many workers who handle the compound.
How DEGME Compares to Its More Toxic Relatives
Glycol ethers are a large chemical family, and they are emphatically not all the same. One of the most important findings from structure-activity research is that DEGME is considerably less potent against the testes than its shorter-chain relative EGME. Japanese experimental studies concluded that both methyl and ethyl ethers of ethylene glycol cause testicular atrophy, with methyl ethers being more potent than ethyl ethers. However, alkyl ethers of diethylene glycol showed no significant effect on the testes.7PubMed Central. Experimental studies on toxicity of ethylene glycol alkyl ethers in Japan
This distinction is critical. EGME, the mono-ethylene glycol version, is one of the most reproductively toxic glycol ethers known. It can damage testes at relatively low doses. DEGME, with its longer diethylene glycol backbone, sidesteps that particular toxicity. That doesn’t make it safe, as the developmental studies above make clear, but it does mean that lumping all glycol ethers together as equally dangerous is inaccurate. The chain length and the specific metabolite produced genuinely change the risk profile.
A parallel distinction exists for blood-cell damage. Glycol ethers with three or four carbon atoms in their alkyl chain tend to cause hemolytic effects as their primary toxicity, while those with one or two carbons (like DEGME’s methyl group) tend to harm the testes before causing measurable hemolysis.8The Journal of Toxicological Sciences. A category approach to predicting the hemolytic effects of ethylene glycol alkyl ethers in repeated-dose toxicity This framework helps regulators predict which health endpoints to worry about for each glycol ether without testing every compound from scratch.
Effects on Blood Cells
Ethylene glycol monoalkyl ethers in general are known to break down red blood cells. The alkoxyacetic acid metabolites are the culprits, and repeated exposure to some family members causes dose- and time-dependent hemolytic anemia in rats, with the effect growing progressively worse over weeks of exposure.9PubMed. Hematological effects of exposure to mixtures of selected ethylene glycol alkyl ethers in rats
Where does DEGME specifically land? In a subchronic dermal exposure study comparing DEGME and EGME in guinea pigs, EGME caused clear hematological changes, but similar changes were not observed in animals exposed to DEGME.10Fundamental and Applied Toxicology. A subchronic dermal exposure study of diethylene glycol monomethyl ether and ethylene glycol monomethyl ether in the male guinea pig This fits the broader pattern: DEGME is less hemotoxic than EGME under comparable conditions. Its primary hazard is developmental toxicity rather than destruction of red blood cells. That said, at sufficiently high or prolonged exposures, no glycol ether with a methyl group can be considered benign to the blood.
Skin Absorption Is a Real Problem
One of the features that makes DEGME more hazardous in practice than its relatively moderate acute toxicity might suggest is how readily it crosses the skin. In an in vitro study using human skin, the diethylene glycol monomethyl ether (labeled DM in the study) penetrated at a rate of about 0.206 mg per square centimeter per hour. That is significantly slower than its mono-ethylene glycol counterpart EGME, which penetrated at roughly 2.82 mg/cm²/hr, but fast enough to deliver a meaningful systemic dose during a work shift if skin contact occurs over a large area or for an extended period.11PubMed Central. Absorption of some glycol ethers through human skin in vitro
A German occupational health assessment reviewed this and related data, concluding that percutaneous absorption is expected to contribute significantly to systemic toxicity. DEGME has accordingly been designated with an “H” notation, a marker meaning that skin absorption is a meaningful route of exposure and that airborne monitoring alone does not adequately protect workers.12PubMed Central. Diethylene glycol monomethyl ether: MAK Value Documentation – Translation of the German version from 2024 For anyone working with DEGME or DEGME-containing products, this is the practical takeaway: wearing gloves and avoiding skin contact matters at least as much as ventilation.
Monitoring Exposure in Workers
Because DEGME breaks down to MEAA in the body, measuring MEAA in urine provides a direct window into how much of the chemical a person has actually absorbed, regardless of whether it entered through the lungs, mouth, or skin. Researchers at NIOSH and affiliated laboratories developed gas chromatographic test methods specifically for this purpose, enabling routine biological monitoring of exposed populations.13CDC Stacks. Urinary (2-Methoxyethoxy) Acetic Acid: An Effective Gas Chromatographic Test Method for Quantification
The results from military fuel-handling studies show that exposure is common and can vary enormously. In a study categorizing Air Force workers by their likely fuel contact, about 94 percent of those in the high-exposure group had detectable MEAA in their urine. The average concentration in that group was 6.8 micrograms per milliliter, with one worker reaching 110 micrograms per milliliter. Workers with moderate exposure showed detection in about a third of samples, with an average of 0.42 micrograms per milliliter. Among those with minimal fuel contact, only about 3 percent had detectable levels.14PubMed. (2-methoxyethoxy)acetic acid: a urinary biomarker of exposure for jet fuel JP-8 The 250-fold gap between the high-exposure average and the low-exposure average underscores how dramatically contact with fuel products drives internal dose. MEAA is also a biomarker for exposure to diglyme (bis(2-methoxyethyl) ether), so detecting it in urine does not by itself identify which specific parent compound a person encountered.15CDC Stacks. Urinary (2-Methoxyethoxy) Acetic Acid: An Effective Gas Chromatographic Test Method for Quantification
Effects on the Liver
At high repeated doses in rats (2,000 mg/kg/day for 20 days), DEGME caused decreases in liver weight and induced certain liver enzymes, specifically cytochrome P-450. It did not, however, affect the activity of alcohol dehydrogenase in the liver, which is the very enzyme responsible for converting DEGME into its toxic metabolite. The practical meaning of this finding is somewhat narrow: DEGME can alter liver biochemistry at high doses, but it does not appear to accelerate or inhibit its own metabolic activation in the liver. EGME, by comparison, produced liver effects at much lower doses (300 mg/kg/day), again reinforcing that the diethylene glycol backbone moderates toxicity across several endpoints.
What Happens in Acute Poisoning
Most real-world DEGME exposures are chronic and low-level, the kind that accumulate over months or years of occupational contact. Acute poisoning from DEGME alone is rare in published case reports, though severe poisoning from glycol ether mixtures does occur. One published case involved a 22-month-old child who accidentally drank up to 330 milliliters of brake fluid containing a blend of glycol ethers, including polyethylene glycol monomethyl ether and several triethylene glycol ethers. Within four hours, the child became drowsy and developed persistent metabolic acidosis. Fomepizole was administered but did not produce noticeable improvement. Hemodialysis, performed about eight hours after ingestion, resolved the symptoms, and the child recovered without lasting harm.16American Academy of Pediatrics (Pediatrics). Severe Poisoning After Accidental Pediatric Ingestion of Glycol Ethers
That case involved a glycol ether mixture rather than pure DEGME, but it illustrates the general approach to severe glycol ether ingestion. The metabolic acidosis is driven by the acidic metabolites produced through alcohol dehydrogenase. Fomepizole blocks that enzyme, and in theory should limit acid production, but in this case it did not halt the progression. Hemodialysis, which physically removes both the parent compounds and their metabolites from the blood, proved decisive. The lesson for emergency physicians is that dialysis should not be delayed while waiting to see if fomepizole works, particularly in a symptomatic patient with confirmed glycol ether ingestion.
Practical Precautions for Exposure
For workers in aviation fuel handling, coating application, or chemical manufacturing who might encounter DEGME, the risk management picture has a few clear priorities. Skin protection ranks at the top. Because DEGME penetrates skin at a meaningful rate, and because airborne monitoring alone underestimates total body burden, chemical-resistant gloves and appropriate coveralls are not optional accessories. Nitrile or butyl rubber gloves are typically recommended for glycol ethers, though the specific glove material should be confirmed against manufacturer breakthrough-time data for DEGME specifically.
Biological monitoring through urine MEAA testing is a stronger indicator of real-world exposure than air sampling alone. Any workplace where workers routinely handle JP-8 or similar fuels containing DEGME should have a biological monitoring program. The wide range of urinary MEAA concentrations seen across military fuel workers suggests that some handling practices or job roles lead to dramatically higher absorption than others, and identifying those high-exposure tasks is the fastest path to reducing risk.
For the general public, direct exposure to DEGME is uncommon. It is not a typical ingredient in consumer household products sold in most Western countries, and its presence in jet fuel is not something passengers encounter. The people at genuine risk are those whose jobs put them in repeated skin or inhalation contact with DEGME-containing materials: fuel handlers, industrial painters, chemical plant operators, and maintenance workers who service fuel systems.
Why DEGME Gets Less Attention Than Other Glycol Ethers
If you follow chemical safety news, you have probably heard of ethylene glycol monomethyl ether (EGME) or 2-butoxyethanol. These glycol ethers have received far more public and regulatory scrutiny than DEGME. Part of the reason is that EGME causes testicular damage at lower doses and through a broader range of exposure routes, making it a more immediate occupational hazard. Another reason is that 2-butoxyethanol appears in consumer cleaning products, giving it a broader exposure base.
DEGME occupies an awkward middle ground. It is toxic enough to warrant serious concern, especially for developmental endpoints, but less overtly dangerous than EGME or certain butyl ethers in day-to-day terms. Its main niche is in military and aviation fuels, where exposure is concentrated among a defined workforce rather than spread across the general population. The result is that DEGME sometimes escapes the public conversation about chemical hazards, even though the developmental toxicity data in rats are striking and the dermal absorption issue is well documented. For the workers who handle it regularly, that relative obscurity is not reassuring; it just means fewer people are paying attention to their exposure.